Pattern of Use of Adjuvant Chemotherapy for Stage II Colon Cancer: A Single-Institution Experience
Authors:
- Jasgit C. SachdevJSJasgit C. Sachdev
- Amna G. KhattakAKAmna G. Khattak
- Lori E. KronishLKLori E. Kronish
- 1 April 2009
- journal article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 8 (2) , 94-99
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathologyGut, 2007
- Lymph Node Evaluation and Survival After Curative Resection of Colon Cancer: Systematic ReviewJNCI: Journal of the National Cancer Institute, 2007
- Population-based study of prognostic factors in stage II colonic cancerBritish Journal of Surgery, 2006
- Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089Journal of Clinical Oncology, 2005
- Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089Journal of Clinical Oncology, 2003
- Adjuvant Chemotherapy Use for Medicare Beneficiaries With Stage II Colon CancerJournal of Clinical Oncology, 2002
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI: Journal of the National Cancer Institute, 1988
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985
- The Prognostic Significance of Tumor Location and Bowel Obstruction in Dukes B and C Colorectal CancerAnnals of Surgery, 1983